These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1388 related items for PubMed ID: 18951217

  • 1. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [Abstract] [Full Text] [Related]

  • 2. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
    Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP.
    Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
    [Abstract] [Full Text] [Related]

  • 3. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI.
    Kim HS, Kim JW, Cho JY, Chung HH, Park NH, Song YS, Kim SH, Kang SB.
    Eur J Surg Oncol; 2009 Aug; 35(8):870-6. PubMed ID: 19179039
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
    Han SS, Lee SH, Kim DH, Kim JW, Park NH, Kang SB, Song YS.
    Acta Obstet Gynecol Scand; 2010 Aug; 89(2):168-74. PubMed ID: 19916890
    [Abstract] [Full Text] [Related]

  • 5. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
    Yavuzcan A, Baloglu A, Cetinkaya B.
    Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer.
    Kolwijck E, Span PN, Thomas CM, Bulten J, Sweep FC, Massuger LF.
    Oncol Rep; 2010 Feb; 23(2):579-84. PubMed ID: 20043124
    [Abstract] [Full Text] [Related]

  • 7. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of Ca 125 levels during primary therapy.
    Markmann S, Gerber B, Briese V.
    Anticancer Res; 2007 Jun; 27(4A):1837-9. PubMed ID: 17649781
    [Abstract] [Full Text] [Related]

  • 9. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.
    Anticancer Res; 2000 Jun; 20(6D):5195-8. PubMed ID: 11326694
    [Abstract] [Full Text] [Related]

  • 10. Preoperative serum CA-125 levels in treating endometrial cancer.
    Powell JL, Hill KA, Shiro BC, Diehl SJ, Gajewski WH.
    J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
    [Abstract] [Full Text] [Related]

  • 11. Value of serum CA125 levels in patients with high-risk, early stage epithelial ovarian cancer.
    Kang WD, Choi HS, Kim SM.
    Gynecol Oncol; 2010 Jan; 116(1):57-60. PubMed ID: 19818996
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.
    van Dalen A, Favier J, Baumgartner L, Hasholzner U, de Bruijn H, Dobbler D, Dombi VH, Fink D, Giai M, McGing P, Harlozinska A, Kainz C, Markowska J, Molina R, Sturgeon C, Einarsson R.
    Anticancer Res; 1999 Jan; 19(4A):2523-6. PubMed ID: 10470187
    [Abstract] [Full Text] [Related]

  • 13. A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer.
    Rossi AC, Di Vagno G, Cormio G, Cazzolla A, Stefanelli S, D'Elia E, Selvaggi L.
    Arch Gynecol Obstet; 2004 May; 269(4):263-5. PubMed ID: 14745561
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Metastatic lymph node number in epithelial ovarian carcinoma: does it have any clinical significance?
    Ayhan A, Gultekin M, Dursun P, Dogan NU, Aksan G, Guven S, Velipasaoglu M, Yuce K.
    Gynecol Oncol; 2008 Feb; 108(2):428-32. PubMed ID: 18249232
    [Abstract] [Full Text] [Related]

  • 17. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M, Ohwada M, Yamada T, Kohno T, Sekiguchi I, Sato I.
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [Abstract] [Full Text] [Related]

  • 18. Association of lymphadenectomy and survival in stage I ovarian cancer patients.
    Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, Osann K.
    Obstet Gynecol; 2007 Jan; 109(1):12-9. PubMed ID: 17197582
    [Abstract] [Full Text] [Related]

  • 19. Cytoreductive surgery for stage IV epithelial ovarian cancer.
    Zang RY, Zhang ZY, Cai SM, Li ZT, Chen J, Tang MQ, Liu Q.
    J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
    [Abstract] [Full Text] [Related]

  • 20. Preoperative predictors for residual tumor after surgery in patients with ovarian carcinoma.
    de Jong D, Eijkemans MJ, Lie Fong S, Gerestein CG, Kooi GS, Baalbergen A, van der Burg ME, Burger CW, Ansink AC.
    Oncology; 2007 Dec; 72(5-6):293-301. PubMed ID: 18198490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.